Regulus Therapeutics (RGLS) News Today $8.16 0.00 (0.00%) As of 06/25/2025 Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RGLS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives $8.50 Average PT from BrokeragesJuly 17 at 2:03 AM | americanbankingnews.comNovartis (NVS) Acquires Regulus Therapeutics for $1.7 BillionJune 28, 2025 | finance.yahoo.comRegulus Therapeutics (NASDAQ:RGLS) Upgraded at Wall Street ZenJune 27, 2025 | marketbeat.comNovartis completes acquisition of Regulus TherapeuticsJune 25, 2025 | globenewswire.comRegulus Therapeutics Inc.June 21, 2025 | barrons.comRegulus Therapeutics (NASDAQ:RGLS) Sees Large Volume Increase - What's Next?June 20, 2025 | marketbeat.comRegulus Therapeutics Inc. (NASDAQ:RGLS) Receives Consensus Rating of "Hold" from AnalystsJune 19, 2025 | marketbeat.comRegulus Therapeutics (NASDAQ:RGLS) Stock Price Crosses Above Two Hundred Day Moving Average - Here's What HappenedJune 18, 2025 | marketbeat.comRegulus Therapeutics (NASDAQ:RGLS) Stock Price Passes Above Two Hundred Day Moving Average - What's Next?June 10, 2025 | marketbeat.comRegulus Therapeutics (NASDAQ:RGLS) Reaches New 12-Month High - Should You Buy?June 6, 2025 | marketbeat.comRegulus Therapeutics Inc. (NASDAQ:RGLS) Insider Buys $95,880.00 in StockJune 5, 2025 | marketbeat.comRegulus Therapeutics (NASDAQ:RGLS) Sees Large Volume Increase Following Insider Buying ActivityJune 5, 2025 | marketbeat.comRegulus Therapeutics Inc. (NASDAQ:RGLS) Insider Preston Klassen Acquires 12,000 SharesJune 5, 2025 | insidertrades.comInsider Buying: Preston Klassen Acquires 12,000 Shares of Regulus Therapeutics Inc (RGLS)June 4, 2025 | gurufocus.comRegulus Therapeutics: An Undervalued Buy, With A $0.90 CVR And A $7 PayoutJune 4, 2025 | seekingalpha.comRegulus Therapeutics Inc. (NASDAQ:RGLS) Short Interest UpdateJune 2, 2025 | marketbeat.comMillennium Management LLC Raises Position in Regulus Therapeutics Inc. (NASDAQ:RGLS)June 1, 2025 | marketbeat.comNorthern Trust Corp Sells 40,071 Shares of Regulus Therapeutics Inc. (NASDAQ:RGLS)June 1, 2025 | marketbeat.comRegulus Therapeutics Inc. (NASDAQ:RGLS) Receives Consensus Recommendation of "Hold" from BrokeragesMay 26, 2025 | marketbeat.comVelan Capital Investment Management LP Makes New Investment in Regulus Therapeutics Inc. (NASDAQ:RGLS)May 22, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Has $47,000 Holdings in Regulus Therapeutics Inc. (NASDAQ:RGLS)May 21, 2025 | marketbeat.comRegulus Therapeutics (NASDAQ:RGLS) Earns Sell Rating from Analysts at StockNews.comMay 20, 2025 | marketbeat.comOctagon Capital Advisors LP Acquires 585,101 Shares of Regulus Therapeutics Inc. (NASDAQ:RGLS)May 15, 2025 | marketbeat.comRegulus Therapeutics (NASDAQ:RGLS) Now Covered by StockNews.comMay 12, 2025 | marketbeat.comRegulus Therapeutics Inc.: Regulus Therapeutics Reports First Quarter 2025 Financial Results and Recent UpdatesMay 9, 2025 | finanznachrichten.deRegulus Therapeutics Reports First Quarter 2025 Financial Results and Recent UpdatesMay 8, 2025 | prnewswire.comWhat is Leerink Partnrs' Estimate for RGLS Q1 Earnings?May 6, 2025 | marketbeat.comJPMorgan Chase & Co. Purchases 111,485 Shares of Regulus Therapeutics Inc. (NASDAQ:RGLS)May 5, 2025 | marketbeat.comREGULUS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Regulus Therapeutics Inc. - RGLSMay 4, 2025 | businesswire.comNovartis (NVS) To Acquire Regulus Therapeutics in $0.8 Billion DealMay 4, 2025 | gurufocus.comRegulus Therapeutics Inc. (NASDAQ:RGLS) Sees Large Decline in Short InterestMay 4, 2025 | marketbeat.comRegulus Therapeutics (NASDAQ:RGLS) Lowered to "Hold" Rating by Wells Fargo & CompanyMay 4, 2025 | marketbeat.comRegulus Therapeutics (NASDAQ:RGLS) Downgraded to "Hold" Rating by Leerink PartnrsMay 4, 2025 | marketbeat.comRegulus Therapeutics Inc. (NASDAQ:RGLS) Shares Sold by RA Capital Management L.P.May 3, 2025 | marketbeat.comRegulus Therapeutics (RGLS) Projected to Post Earnings on ThursdayMay 3, 2025 | marketbeat.comWells Fargo Downgrades Regulus Therapeutics (RGLS)May 2, 2025 | msn.comNovartis to buy Regulus Therapeutics for as much as $1.7 billionMay 2, 2025 | latimes.comRegulus Therapeutics (NASDAQ:RGLS) Shares Pass Above 200-Day Moving Average - Here's What HappenedMay 2, 2025 | marketbeat.comJones Trading Downgrades Regulus Therapeutics (RGLS)May 1, 2025 | msn.comNovartis Acquires Regulus Therapeutics for $800 MillionMay 1, 2025 | gurufocus.comNovartis to Acquire Regulus Therapeutics in $1.7 Billion DealMay 1, 2025 | gurufocus.comRegulus Therapeutics Acquisition By Novartis Due To Key Farabursen AdvancementsApril 30, 2025 | seekingalpha.comRegulus Therapeutics Inc.: Regulus Therapeutics Enters into Agreement to be Acquired by Novartis AGApril 30, 2025 | finanznachrichten.deRegulus Therapeutics stock soars on acquisition deal with NovartisApril 30, 2025 | za.investing.comNovartis to buy kidney disease drug maker Regulus in up to $1.7 billion dealApril 30, 2025 | msn.comRegulus Therapeutics Stock Skyrockets On $1.7B Acquisition Offer From NovartisApril 30, 2025 | msn.comRegulus Therapeutics Acquisition By Novartis Due To Key Farabursen AdvancementsApril 30, 2025 | seekingalpha.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Regulus Therapeutics Inc. - RGLSApril 30, 2025 | prnewswire.comCrude Oil Falls Over 3%; Regulus Therapeutics Shares Spike HigherApril 30, 2025 | benzinga.comNovartis To Buy US Kidney Drug Developer Regulus Therapeutics For Around $800 MillionApril 30, 2025 | benzinga.com Get Regulus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RGLS and its competitors with MarketBeat's FREE daily newsletter. Email Address RGLS Media Mentions By Week RGLS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RGLS News Sentiment▼0.000.59▲Average Medical News Sentiment RGLS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RGLS Articles This Week▼13▲RGLS Articles Average Week Get Regulus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RGLS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amicus Therapeutics News BioCryst Pharmaceuticals News Celldex Therapeutics News Dynavax Technologies News Innoviva News MannKind News Novavax News OPKO Health News Geron News Zenas BioPharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RGLS) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regulus Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regulus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
